

The Healthcare Microfluidics market is experiencing significant growth, driven by increasing demand for point-of-care diagnostics and personalized medicine. Valued at approximately $9 billion in 2023, the market is projected to expand due to technological advancements and rising investments, with a compound annual growth rate (CAGR) exceeding 15% through 2030. Request Sample Report
◍ Abbott Laboratories
◍ Agilent Technologies, Inc.
◍ BD
◍ Bio-Rad Laboratories
◍ Danaher Corporation
◍ Roche
◍ IDEX Corporation
◍ PerkinElmer
◍ Thermo Fisher Scientific
The healthcare microfluidics market features key players like Abbott Laboratories, Agilent Technologies, and Roche, focusing on diagnostics and drug delivery innovations. These companies enhance market growth through advanced technologies and strategic collaborations. Select revenue figures include: Abbott: $43 billion, Thermo Fisher: $39 billion, and Roche: $65 billion. Request Sample Report
Homecare
Hospitals
Others
Request Sample Report
Glass Based
Polymer Based
Silicon Based
Others
Request Sample Report
$ X Billion USD